Neutec Pharma

Developer of recombinant antibody therapies for infectious diseases

placeManchester, England, United Kingdom calendar_todayFounded 1996 groups20 employees language neutecpharma.com

Registered entities

Investor mix

7 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital114%
Private equity114%
Other / undisclosed571%
Coming soon